Measles virus (MV) was isolated in 1954 (Enders and Peeble 1954). It is among the most contagious of viruses and a leading cause of mortality in children in developing countries (Murray and Lopez 1997; Griffin 2001; Bryce et al. 2005). Despite intense research over decades on the biology and pathogenesis of the virus and the successful development in 1963 of an effective MV vaccine (Cutts and Markowitz 1994), cell entry receptor(s) for MV remained unidentified until 1993. Two independent studies showed that transfection of nonsusceptible rodent cells with human CD46 renders these cells permissive to infection with the Edmonston and Halle vaccine strains of measles virus (Dorig et al. 1993; Naniche et al. 1993). A key finding in these investigations was that MV binding and infection was inhibited by monoclonal and polyclonal antibodies to CD46. These reports established CD46 as a MV cell entry receptor. This chapter summarizes the role of CD46 inmeasles virus infection.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
- Hemolytic Uremic Syndrome
- Measle Virus
- Bovine Viral Diarrhea Virus
- Membrane Cofactor Protein
- CD46 Downregulation
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Adams EM, Brown MC, Nunge M, Krych M, Atkinson JP (1991) Contribution of the repeating domains of membrane cofactor protein (CD46) of the complement system to ligand binding and cofactor activity. J Immunol 147:3005–3011
Andres O, Obojes K, Kim KS, ter Meulen V, Schneider-Schaulies J (2003) CD46- and CD 150-independent endothelial cell infection with wild-type measles viruses. J Gen Virol 84:1189–1197
Astier A, Trescol-Biemont M-C, Azocar O, Lamouille B, Rabourdin-Combe C (2000) Cutting edge: CD46, a new costimulatory molecule for T cells, that induces p120 CBL and LAT phos-phorylation. J Immunol 164:6091–6095
Atabani SF, Byrnes AA, Jaye A et al (2001) Natural measles causes prolonged suppression of interleukin-12 production. J Infect Dis 184:1–9
Barlow PN, Baron M, Norman DG et al (1991) Secondary structure of a complement control protein module by two-dimensional 1H NMR. Biochemistry (Mosc) 30:997–1004
Bartz R, Brinckmann U, Dunster LM, Rima B, Ter Meulen V, Schneider-Schaulies J (1996)Mapping amino acids of the measles virus hemagglutinin responsible for receptor (CD46) downregulation. Virology 224:334–337
Bartz R, Firsching R, Rima B, ter Meulen V, Schneider-Schaulies J (1998) Differential receptor usage by measles virus strains. J Gen Virol 79:1015–1025
Bieback K, Lien E, Klagge IM et al (2002) Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol 76:8729–8736
Blixenkrone-Moeller M, Bernard A, Bencsik A et al (1998) Role of CD46 in measles virus infection in CD46 transgenic mice. Virology 249:238–248
Bluestone JA, Abbas AK (2003) Natural versus adaptive regulatory T cells. Nat Rev Immunol 3:253–257
Bryce J, Boschi-Pinto C, Shibuya K, Black RE (2005) WHO estimates of the causes of death in children. Lancet 365(9465):1147–1152
Buchholz CJ, Gerlier D, Hu A et al (1996) Selective expression of a subset of measles virus receptor-competent CD46 isoforms in human brain. Virology 217:349–355
Buchholz CJ, Koller D, Devaux P et al (1997) Mapping of the primary binding site of measles virus to its receptor CD46. J Biol Chem 272:22072–22079
Buckland R, Wild TF (1997) Is CD46 the cellular receptor for measles virus? Virus Res 48:1–9
Caprioli J, Peng L, Remuzzi G (2005) The hemolytic uremic syndromes. Curr Opin Crit Care 11:487–492
Caprioli J, Noris M, Brioschi S et al (2006) Genetics of HUS: the impact of MCP, CFH and IF mutations on clinical presentation, response to treatment, and outcome. Blood 108:1267–1279
Casasnovas JM, Larvie M, Stehle T (1999) Crystal structure of two CD46 domains reveals an extended measles virus-binding surface. EMBO J 18:2911–2922
Cattaneo R (2004) Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet. J Virol 78:4385–4388
Christiansen D, Deleage G, Gerlier D (2000a) Evidence for distinct complement regulatory and measles virus binding sites on CD46 SCR2. Eur J Immunol 30:3457–3462
Christiansen D, Devaux P, Reveil B et al (2000b) Octamerization enables soluble CD46 receptor to neutralize measles virus in vitro and in vivo. J Virol 74:4672–4678
Cole JL, Housley GA Jr, Dykman TR, MacDermott RP, Atkinson JP (1985) Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines. Proc Natl Acad Sci U S A 82:859–863
Colf LA, Juo ZS, Garcia KC (2007) Structure of the measles virus hemagglutinin. Nat Struct Mol Biol 14:1227–1228
Crimeen-Irwin B, Ellis S, Christiansen D et al (2003) Ligand binding determines whether CD46 is internalized by clathrin-coated pits or macropinocytosis. J Biol Chem 278:46927–46937
Cui W, Hourcade D, Post TW, Greenlund AC, Atkinson JP, Kumar V (1993) Characterization of the promoter region of the membrane cofactor protein (CD46) gene of the human complement system and comparison to a membrane cofactor protein-like genetic element. J Immunol 151:4137–4146
Cutts FT, Markowitz LE (1994) Successes and failures in measles control. J Infect Dis 170 [Suppl 1]:S32–S41
de Cordoba SR, Dykman TR, Ginsberg-Fellner F et al (1984) Evidence for linkage between the loci coding for the binding protein for the fourth component of human complement ( C4BP)and for the C3b/C4b receptor. Proc Natl Acad Sci U S A 81:7890–7892
de Witte L, Abt M, Schneider-Schaulies S, van Kooyk Y, Geijtenbeek TB (2006) Measles virus targets DC-SIGN to enhance dendritic cell infection. J Virol 80:3477–3486
Devaux P, Loveland BE, Christiansen D, Millane J, Gerlier D (1996) Interaction between the ectodomains of haemagglutinin and CD46 as a primary step in measles virus entry. J Gen Virol 77:1477–1481
Dhiman N, Jacobson RM, Poland GA (2004) Measles virus receptors: SLAM and CD46. Rev Med Virol 14:217–229
Dorig RE, Marcil A, Chopra A, Richardson CD (1993) The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75:295–305
Elward K, Griffiths M, Mizuno M et al (2005) CD46 plays a key role in tailoring innate immune recognition of apoptotic and necrotic cells. J Biol Chem 280:36342–3654
Enders JF, Peebles TC (1954) Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc Soc Exp Biol Med 86:277–286
Erlenhofer C, Duprex WP, Rima BK, ter Meulen V, Schneider-Schaulies J (2002) Analysis of receptor (CD46, CD150) usage by measles virus. J Gen Virol 83:1431–1436
Evlashev A, Moyse E, Valentin H et al (2000) Productive measles virus brain infection and apop-tosis in CD46 transgenic mice. J Virol 74:1373–1382
Evlashev A, Valentin H, Rivailler P, Azocar O, Rabourdin-Combe C, Horvat B (2001) Differential permissivity to measles virus infection of human and CD46-transgenic murine lymphocytes.J Gen Virol 82:2125–2129
Fleischli C, Verhaagh S, Havenga M, et al (2005) The distal short consensus repeats 1 and 2 of the membrane cofactor protein CD46 and their distance from the cell membrane determine productive entry of species B adenovirus serotype 35. J Virol 79:10013–10022
Gaggar A, Shayakhmetov DM, Lieber A (2003) CD46 is a cellular receptor for group B adenovi-ruses. Nat Med 9:1408–1412
Galbraith SE, Tiwari A, Baron MD, Lund BT, Barrett T, Cosby SL (1998) Morbillivirus down-regulation of CD46. J Virol 72:10292–10297
Gerlier D, Loveland BE, Varion-Krishnan G, Thorley B, McKenzie IFC, Rabaudin-Combe C (1994a) Efficient major histocompatibility complex class II-restricted presentation of measles virus relies on hemagglutinin-mediated targeting to its cellular receptor human CD46 expressed by murine B cell. J Exp Med 179:353–358
Gerlier D, Trescol-Biemont MC, Varior-Krishnan G, Naniche D, Fugier-Vivier I, Rabourdin-Combe C (1994b) Efficient major histocompatibility complex class II-restricted presentation of measles virus relies on hemagglutinin-mediated targeting to its cellular receptor human CD46 expressed by murine B cells. J Exp Med 179:353–358
Gerlier D, Valentin H, Laine D, Rabourdin-Combe C, Servet-Delprat C (2006) Subversion of the immune system by measles virus: a model for the intricate interplay between a virus and the human immune system. In: Lachmann PJ, Oldstone MBA (eds) Microbial subversion of immunity: current topics. Caister Academic, Norfolk, UK, pp 225–292
Giannakis E, Jokiranta TS, Ormsby RJ et al (2002) Identification of the streptococcal M protein binding site on membrane cofactor protein (CD46). J Immunol 168:4585–4592
Gill D, Atkinson J (2004) CD46 in Neisseria pathogenesis. Trends Mol Med 10:459–465
Gill DB, Koomey M, Cannon JG, Atkinson JP (2003) Down-regulation of CD46 by piliated Neisseria gonorrhoeae. J Exp Med 198:1313–1322
Gorelick A, Oglesby TJ, Rashbaum W, Atkinson JP, Buyon JP (1995) Ontogeny of membrane cofactor protein: phenotypic divergence in the fetal heart. Lupus 4:293–296
Greenstone HL, Santoro F, Lusso P, Berger EA (2002) Human herpesvirus 6 and measles virus employ distinct CD46 domains for receptor function. J Biol Chem 277:39112–39118
Griffin DE (2001) Measles virus. In: Knipe DM, Howley PM, Griffin DE et al (eds) Fields virology. 4th edn. Lippincott Williams ' Wilkins, Philadelphia, pp 1401–1441
Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ (2004a) Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21:589–601
Grossman WJ, Verbsky JW, Tollefsen BL, Kemper C, Atkinson JP, Ley TJ (2004b) Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 104:2840–2848
Groux H (2001) An overview of regulatory T cells. Microbes Infect 3:883–889
Groux H, O'Garra A, Bigler M et al (1997) A CD4 + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737–742
Hadam MR (1989) Cluster report: CD. In: Knapp W (ed) Leucocyte type I V. Oxford Universtiy Press, Oxford, pp 649–652
Hahm B, Arbour N, Naniche D, Homann D, Manchester M, Oldstone MB (2003) Measles virus infects and suppresses proliferation of T lymphocytes from transgenic mice bearing human signaling lymphocytic activation molecule. J Virol 77:3505–3515
Hahm B, Arbour N, Oldstone MB (2004) Measles virus interacts with human SLAM receptor on dendritic cells to cause immunosuppression. Virology 323:292–302
Hakulinen J, Keski-Oja J (2006) ADAM10-mediated release of complement membrane cofactor protein during apoptosis of epithelial cells. J Biol Chem 281:21369–1376
Hall WC, Kovatch RM, Herman PH, Fox JG (1971) Pathology of measles in rhesus monkeys. Vet Pathol 8:307–319
Hara T, Kuriyama S, Kiyohara H, Nagase Y, Matsumoto M, Seya T (1992) Soluble forms of membrane cofactor protein (CD46, MCP) are present in plasma, tears, and seminal fluid in normal subjects. Clin Exp Immunol 89:490–494
Hara T, Suzuki Y, Semba T, Hatanaka M, Matsumoto M, Seya T (1995) High expression of membrane cofactor protein of complement (CD46) in human leukaemia cell lines: implication of an alternatively spliced form containing the STA domain in CD46 up-regulation. Scand J Immunol 42:581–590
Harris CL, Mizuno M, Morgan BP (2006) Complement and complement regulators in the male reproductive system. Mol Immunol 43:57–67
Hashimoto K, Ono N, Tatsuo H et al (2002) SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J Virol 76:6743–6749
Hawlisch H, Kohl J (2006) Complement and Toll-like receptors: key regulators of adaptive immune responses. Mol Immunol 43:13–21
Hirano A, Kurita-Taniguchi M, Katayama Y, Matsumoto M, Wong TC, Seya T (2002) Ligation of human CD46 with purified complement C3b or F(ab′)2 of monoclonal antibodies enhances isoform-specific interferon gamma-dependent nitric oxide production in macrophages.J Biochem (Tokyo) 132:83–91
Holers VM, Cole JL, Lublin DM, Seya T, Atkinson JP (1985) Human C3b- and C4b-regulatory proteins: a new multi-gene family. Immunol Today 6:188–192
Horvat B, Rivailler P, Varior-Krishnan G, Cardoso A, Gerlier D, Rabourdin-Combe C (1996) Transgenic mice expressing human measles virus (MV) receptor CD46 provide cells exhibiting different permissivities to MV infections. J Virol 70:6673–6681
Hosokawa M, Nonaka M, Okada N, Okada H (1996) Molecular cloning of guinea pig membrane cofactor protein: preferential expression in testis. J Immunol 157:4946–4952
Hourcade D, Holers VM, Atkinson JP (1989) The regulators of complement activation (RCA) gene cluster. Adv Immunol 45:381–416
Hourcade D, Liszewski MK, Kruch-Goldberg M, Atkinson SP (2000) Functional domains,structural variations and pathogen interactions of MCP, DAF, and CRI. Immunopharmacology 49:103–116
Hourcade D, Post TW, Holers VM, Lublin DM, Atkinson JP (1990) Polymorphisms of the regulators of complement activation (RCA) gene cluster. Complement Inflamm 17:302–314
Hsu EC, Dorig RE, Sarangi F, Marcil A, Iorio C, Richardson CD (1997) Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding. J Virol 71:6144–6154
Hsu EC, Sarangi F, Iorio C et al (1998) A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells. J Virol 72:2905–2916
Iacobelli-Martinez M, Nepomuceno RR, Connolly J, Nemerow GR (2005) CD46-utilizing adenoviruses inhibit C/EBPbeta-dependent expression of proinflammatory cytokines. J Virol 79:11259–11268
Inoue N, Ikawa M, Nakanishi T et al (2003) Disruption of mouse CD46 causes an accelerated spontaneous acrosome reaction in sperm. Mol Cell Biol 23:2614–2622
Iwata K, Seya T, Ueda S, Ariga H, Nagasawa S (1994) Modulation of complement regulatory function and measles virus receptor function by the serine-threonine-rich domains of membrane cofactor protein (CD46). Biochem J 304:169–175
Iwata K, Seya T, Yanagi Y et al (1995) Diversity of sites for measles virus binding and for inacti-vation of complement C3b and C4b on membrane cofactor protein CD46. J Biol Chem 270:15148–15152
Johansson L, Rytkonen A, Bergman P et al (2003) CD46 in meningococcal disease. Science 301:373–375
Johnston IC, ter Meulen V, Schneider-Schaulies J, Schneider-Schaulies S (1999) A recombinant measles vaccine virus expressing wild-type glycoproteins: consequences for viral spread and cell tropism. J Virol 73:6903–6915
Johnstone RW, Russell SM, Loveland BE, McKenzie IF (1993) Polymorphic expression of CD46 protein isoforms due to tissue-specific RNA splicing. Mol Immunol 30:1231–1241
Kallstrom H, Islam MS, Berggren PO, Jonsson AB (1998) Cell signaling by the type IV pili of pathogenic Neisseria. J Biol Chem 273:21777–21782
Kallstrom H, Blackmer Gill D, Albiger B, Liszewski MK, Atkinson JP, Jonsson AB (2001)Attachment of Neisseria gonorrhoeae to the cellular pilus receptor CD46: identification of domains important for bacterial adherence. Cell Microbiol 3:133–143
Karp CL (1999) Measles: immunosuppression, interleukin-12, and complement receptors. Immunol Rev 168:91–101
Karp CL, Wysocka M, Wahl LM et al (1996) Mechanism of suppression of cell-mediated immunity by measles virus. [Erratum appears in Science 1997 Feb 21; 275(5303):1053]. Science 273:228–231
Katayama Y, Hirano A, Wong TC (2000) Human receptor for measles virus (CD46) enhances nitric oxide production and restricts virus replication in mouse macrophages by modulating production of alpha/beta interferon. J Virol 74:1252–1257
Kavanagh D, Richards A, Atkinson J (2008) Complement regulatory genes and hemolytic uremic syndromes. Annu Rev Med 59:293–309
Kemper C, Atkinson JP (2007) T-cell regulation: with complements from innate immunity. Nat Rev Immunol 7:9–18
Kemper C, Leung M, Stephensen CB et al (2001) Membrane cofactor protein (MCP; CD46)expression in transgenic mice. Clin Exp Immunol 124:180–189
Kemper C, Chan AC, Green JM, Brett KA, Murphy KM, Atkinson JP (2003) Activation of human CD4 + cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421:388–392
Kemper C, Verbsky JW, Price JD, Atkinson JP (2005) T-cell stimulation and regulation: with complements from CD46. Immunol Res 32:31–43
Kerdiles YM, Sellin CI, Druelle J, Horvat B (2006) Immunosuppression caused by measles virus:role of viral proteins. Rev Med Virol 16:49–63
Kim YU, Kinoshita T, Molina H et al (1995) Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay accelerating factor and membrane cofactor protein. J Exp Med 181:151–159
Kitamura M, Matsumiya K, Yamanaka M et al (1997) Possible association of infertility with sperm-specific abnormality of CD46. J Reprod Immunol 33:83–88
Kohl J, Bitter-Suermann D (1993) Anaphylatoxins. In: Whaley K, Loos M, Weiler JM, (eds) Immunology and medicine: complement in health disease. 2nd edn. Kluwer Academic,Boston, pp 299–324
Krey T, Himmelreich A, Heimann M et al (2006) Function of bovine CD46 as a cellular receptor for bovine viral diarrhea virus is determined by complement control protein 1. J Virol 80:3912–3922
Kurita-Taniguchi M, Fukui A, Hazeki K et al (2000) Functional modulation of human macro-phages through CD46 (measles virus receptor): production of IL-12 p40 and nitric oxide in association with recruitment of protein-thyroxine phosphatase SHP-1 to CD46. J Immunol 165:5143–5152
Kusuhara K, Sasaki Y, Nakao F et al (2000) Analysis of measles virus binding sites of the CD46 gene in patients with subacute sclerosing panencephalitis. J Infect Dis 181:1447–1449
Lecouturier V, Fayolle J, Caballero M et al (1996) Identification of two amino acids in the hemag-glutinin glycoprotein of measles virus (MV) that govern hemadsorption, HeLa cell fusion, and CD46 downregulation: phenotypic markers that differentiate vaccine and wild-type MV strains. J Virol 70:4200–4204
Lee SW, Bonnah RA, Higashi DL, Atkinson JP, Milgram SL, So M (2002) CD46 is phosphor-ylated at tyrosine 354 upon infection of epithelial cells by Neisseria gonorrhoeae. J Cell Biol 156:951–957
Li K, Feito MJ, Sacks SH, Sheerin NS (2006) CD46 (membrane cofactor protein) acts as a human epithelial cell receptor for internalization of opsonized uropathogenic Escherichia coli.J Immunol 177:2543–2551
Li L, Qi Y (2002) A novel amino acid position in hemagglutinin glycoprotein of measles virus is responsible for hemadsorption and CD46 binding. Arch Virol 147:775–786
Liszewski MK, Atkinson JP (1992) Membrane cofactor protein. Curr Top Microbiol Immunol 178:45–60
Liszewski MK, Farries TC, Lublin DM, Rooney IA, Atkinson JP (1996) Control of the complement system. Adv Immunol 41:201–283
Liszewski MK, Post TW, Atkinson JP (1991) Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu Rev Immunol 9:431–455
Ludford-Menting MJ, Thomas SJ, Crimeen B et al (2002) A functional interaction between CD46 and DLG4: a role for DLG4 in epithelial polarization. J Biol Chem 277:4477–4484
Maisner A, Herrler G (1995) Membrane cofactor protein with different types of N-glycans can serve as measles virus receptor. Virology 210:479–481
Maisner A, Schneider-Schaulies J, Liszewski MK, Atkinson JP, Herrler G (1994) Binding of measles virus to membrane cofactor protein (CD46): importance of disulfide bonds and N-glycans for the receptor function. J Virol 68:6299–6304
Maisner A, Alvarez J, Liszewski MK, Atkinson JP, Atkinson D, Herrler G (1996) The N-glycan of the SCR 2 region is essential for membrane cofactor protein (CD46) to function as measles virus receptor. J Virol 70:4973–4977
Manchester M, Gairin JE, Alvarez J, Liszewski MK, Atkinson JP, Oldstone MBA (1997) Measles virus recognizes its receptor, CD46, via two distinct binding domains within SCR1–2.Virology 233:174–187
Manchester M, Rall GF (2001) Model systems: transgenic mouse models for measles pathogene-sis. Trends Microbiol 9:19–23
Manchester M, Eto DS, Valsamakis A et al (2000a) Clinical isolates of measles virus use CD46 as a cellular receptor. J Virol 74:3967–3974
Manchester M, Naniche D, Stehle T (2000b) CD46 as a measles receptor: form follows function.Virology 274:5–10
Marie JC, Kehren J, Trescol-Biemont MC et al (2001) Mechanism of measles virus-induced suppression of inflammatory immune responses. Immunity 14:69–79
Marie J, Astier AL, Rivailler P, Rabourdin-Combe C, Wild TF, Horvat B (2002) Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell-induced inflammation. Nat Immunol 3:659–666
Masse N, Barrett T, Muller CP, Wild TF, Buckland R (2002) Identification of a second major site for CD46 binding in the hemagglutinin protein from a laboratory strain of measles virus (MV):potential consequences for wild-type MV infection. J Virol 76:13034–13038
Masse N, Ainouze M, Neel B, Wild TF, Buckland R, Langedijk JP (2004) Measles virus (MV)hemagglutinin: evidence that attachment sites for MV receptors SLAM and CD46 overlap on the globular head. J Virol 78:9051–9063
Matsumoto M, Seya T, Nagasawa S (1992) Polymorphism and proteolytic fragments of granulo-cyte membrane cofactor protein (MCP, CD46) of complement. Biochem J 281:493–499
Maurer K, Krey T, Moennig V, Thiel HJ, Rumenapf T (2004) CD46 is a cellular receptor for bovine viral diarrhea virus. J Virol 78:1792–1799
Medzhitov R, Preston-Hurlburt P, Janeway CAJ (1997) A human homologue of the iDrosophilia Toll protein signals activation of adaptive immunity. Nature 388:394–397
Meiffren G, Flacher M, Azocar O, Rabourdin-Combe C, Faure M (2006) Cutting edge: abortive proliferation of CD46-induced Tr1-like cells due to a defective Akt/Survivin signaling pathway. J Immunol 177:4957–4961
Morgan BP, Harris CL (1999) Complement regulatory proteins. Academic Press, New York
Mori Y, Seya T, Huang HL, Akkapaiboon P, Dhepakson P, Yamanishi K (2002) Human herpesvi-rus 6 variant A but not variant B induces fusion from without in a variety of human cells through a human herpesvirus 6 entry receptor, CD46. J Virol 76:6750–6761
Mori Y, Yang X, Akkapaiboon P, Okuno T, Yamanishi K (2003) Human herpesvirus 6 variant Aglycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46. J Virol 77:4992–4999
Mrkic B, Pavlovic J, Rulicke T et al (1998) Measles virus spread and pathogenesis in genetically modified mice. J Virol 72:7420–7427
Mumenthaler C, Schneider U, Buchholz CJ, Koller D, Braun W, Cattaneo R (1997) A 3D model for the measles virus receptor CD46 based on homology modeling, Monte Carlo simulations,and hemagglutinin binding studies. Protein Sci 6:588–597
Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 349(9064):1498–1504
Naniche D, Varior-Krishnan G, Cervoni F et al (1993) Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 67:6025–6032
Naniche D, Yeh A, Eto D, Manchester M, Friedman RM, Oldstone MB (2000) Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of alpha/beta interferon production. J Virol 74:7478–7484
Niewiesk S (1999) Cotton rats ( Sigmodon hispidus ): an animal model to study the pathogenesis of measles virus infection. Immunol Lett 65:47–50
Niewiesk S, Schneider-Schaulies J, Ohnimus H et al (1997) CD46 expression does not overcome the intracellular block of measles virus replication in transgenic mice. J Virol 71:7969–7973
Oldstone MB, Lewicki H, Thomas D et al (1999) Measles virus infection in a transgenic model:virus-induced immunosuppression and central nervous system disease. Cell 98:629–640
Oliaro J, Pasam A, Waterhouse NJ et al (2006) Ligation of the cell surface receptor, CD46, alters T cell polarity and response to antigen presentation. Proc Natl Acad Sci U S A 103:18685–18690
Ono N, Tatsuo H, Tanaka K, Minagawa H, Yanagi Y (2001) V domain of human SLAM (CDw150) is essential for its function as a measles virus receptor. J Virol 75:1594–1600
Peng KW, Frenzke M, Myers R et al (2003) Biodistribution of oncolytic measles virus after intra-peritoneal administration into Ifnar-CD46Ge transgenic mice. Hum Gene Ther 14:1565–1577
Persson BD, Reiter DM, Marttila M et al (2007) Adenovirus type 11 binding alters the conformation of its receptor CD46. Nat Struct Mol Biol 14:164–166
Price JD, Schaumburg J, Sandin C, Atkinson JP, Lindahl G, Kemper C (2005) Induction of a regulatory phenotype in human CD4 + T cells by streptococcal M protein. J Immunol 175:677–684
Purcell DFJ, Russell SM, Deacon NJ, Brown MA, Hooker DJ, McKenzie IFC (1991) Alternatively spliced RNAs encode several isoforms of CD46 (MCP), a regulator of complement activation.Immunogenetics 33:335–344
Rall GF, Manchester M, Daniels LR, Callahan EM, Belman AR, Oldstone MB (1997) A transgenic mouse model for measles virus infection of the brain. Proc Natl Acad Sci U S A 94:4659–4663
Reid KBM, Bentley DR, Campbell RD et al (1986) Complement system proteins which interact with C3b or C4b. Immunol Today 7:230
Richards A, Kemp EJ, Liszewski MK et al (2003) Mutations in human complement regulator,membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci U S A 100:12966–12971
Richards A, Kavanagh D, Atkinson JP (2007) Inherited complement regulatory protein deficiencypredisposes to human disease in acute injury and chronic inflammatory states. Adv Immunol 97:141–177
Riley RC, Tannenbaum PL, Abbott DH, Atkinson JP (2002) Cutting edge: Inhibiting measles virus infection but promoting reproduction: an explanation for splicing and tissue-specifi expression of CD46. J Immunol 169:5405–5409
Riley-Vargas RC, Atkinson JP (2003) Expression of membrane cofactor protein (MCP; CD46) on spermatozoa: just a complement inhibitor? Mod Aspects Immunobiol 3:75–78
Riley-Vargas RC, Gill DB, Kemper C, Liszewski MK, Atkinson JP (2004) CD46: expanding beyond complement regulation. Trends Immunol 25:496–503
Riley-Vargas RC, Lanzendorf S, Atkinson JP (2005) Targeted and restricted complement activation on acrosome-reacted spermatozoa. J Clin Invest 115:1241–1249
Rima BK, Earle JA, Baczko K et al (1997) Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture. J Gen Virol 78:97–106
Rivailler P, Trescol-Biemont MC, Gimenez C, Rabourdin-Combe C, Horvat B (1998) Enhanced MHC class II-restricted presentation of measles virus (MV) hemagglutinin in transgenic mice expressing human MV receptor CD46. Eur J Immunol 28:1301–1314
Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK (2001) Type 1 regulatory cells.Immunol Rev 182:68–79
Russell SM, Sparrow RL, McKenzie IFC, Purcell DFJ (1992) Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing. Eur J Immunol 22:1513–1518
Sakaguchi S (2000) Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101:455–458
Sanchez A, Feito MJ, Rojo JM (2004) CD46-mediated costimulation induces a Th1-biased response and enhances early TCR/CD3 signaling in human CD4 + T lymphocytes. Eur J Immunol 34:2439–2448
Santiago C, Bjorling E, Stehle T, Casasnovas JM (2002) Distinct kinetics for binding of the CD46 and SLAM receptors to overlapping sites in the measles virus hemagglutinin protein. J Biol Chem 277:32294–32301
Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA, Lusso P (1999) CD46 is a cellular receptor for human herpesvirus 6. Cell 99:817–827
Santoro F, Greenstone HL, Insinga A et al (2003) Interaction of glycoprotein H of human herpes-virus 6 with the cellular receptor CD46. J Biol Chem 278:25964–25969
Schneider-Schaulies J, Dunster LM, Kobune F, Rima B, ter Meulen V (1995) Differential down-regulation of CD46 by measles virus strains. J Virol 69:7257–7259
Schnoor J-J, Dunster LM, Nanan R, Schneider-Schaulies J, Schneider-Schaulies S, ter Meulen V (1995) Measles virus-induced down-regulation of CD46 is associated with enhanced sensitivity to complement-mediated lysis of infected cells. Eur J Immunol 25:976–984
Segerman A, Atkinson JP, Marttila M, Dennerquist V, Wadell G, Arnberg N (2003) Adenovirus type 11 uses CD46 as a cellular receptor. J Virol 77:9183–9191
Seki F, Takeda M, Minagawa H, Yanagi Y (2006) Recombinant wild-type measles virus containing a single N481Y substitution in its haemagglutinin cannot use receptor CD46 as efficiently as that having the haemagglutinin of the Edmonston laboratory strain. J Gen Virol 87:1643–1648
Seya T, Turner JR, Atkinson JP (1986) Purification and characterization of a membrane protein (gp45–70) that is a cofactor for cleavage of C3b and C4b. J Exp Med 163:837–855
Seya T, Ballard LL, Bora NS, Kumar V, Cui W, Atkinson JP (1988) Distribution of membrane cofactor protein (MCP) of complement on human peripheral blood cells. An altered form is found on granulocytes. Eur J Immunol 18:1289–1294
Seya T, Hirano A, Matsumoto M, Nomura M, Ueda S (1999) Human membrane cofactor protein (MCP, CD46): multiple isoforms and functions. Int J Biochem Cell Biol 31:1255–1260
Shibahara K, Hotta H, Katayama Y, Homma M (1994) Increased binding activity of measles virus to monkey red blood cells after long-term passage in Vero cell cultures. J Gen Virol 75:3511–3516
Shingai M, Inoue N, Okuno T et al (2005) Wild-type measles virus infection in human CD46/CD150-transgenic mice: CD11c-positive dendritic cells establish systemic viral infection. J Immunol 175:3252–3261
Simpson KL, Holmes CH (1994) Presence of the complement-regulatory protein membrane cofactor protein (MCP, CD46) as a membrane-associated product in seminal plasma. J Reprod Fertil 102:419–424
Smith A, Santoro F, Di Lullo G, Dagna L, Verani A, Lusso P (2003) Selective suppression of IL-12 production by human herpesvirus 6. Blood 102:2877–2884
Takeuchi K, Takeda M, Miyajima N, Kobune F, Tanabayashi K, Tashiro M (2002) Recombinant wild-type and Edmonston strain measles viruses bearing heterologous H proteins: role of H protein in cell fusion and host cell specificity. J Virol 76:4891–4900
Tatsuo H, Ono N, Tanaka K, Yanagi Y (2000) SLAM (CDw150) is a cellular receptor for measles virus. Nature 406(6798):893–897
Thorley BR, Milland J, Christiansen D et al (1997) Transgenic expression of a CD46 (membrane cofactor protein) minigene: studies of xenotransplantation and measles virus infection. Eur J Immunol 27:726–734
Tsujimura A, Shida K, Kitamura M et al (1998) Molecular cloning of a murine homologue of membrane cofactor protein (CD46): preferential expression in testicular germ cells. Biochem J 330:163–168
van Binnendijk RS, van der Heijden RW, Osterhaus AD (1995) Monkeys in measles research.Curr Top Microb Immunol 191:135–148
Varior-Krishnan G, Trescol-Biemont MC, Naniche D, Rabourdin-Combe C, Gerlier D (1994) Glycosyl-phosphatidylinositol-anchored and transmembrane forms of CD46 display similar measles virus receptor properties: virus binding, fusion, and replication; down-regulation by hemagglutinin and virus uptake and endocytosis for antigen presentation by major histocom-patibility complex class II molecules. J Virol 68:7891–7989
Vongpunsawad S, Oezgun N, Braun W, Cattaneo R (2004) Selectively receptor-blind measles viruses: identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model. J Virol 78:302–313
Walport MJ (2001) Complement. First of two parts. N Engl J Med 344:1058–1066
Walport MJ (2001) Complement. Second of two parts. N Engl J Med 344:1140–1144
Whaley K, Loos M, Weiler JM (1993) Complement in health and disease. 2nd edn. Kluwer Academic, London
Wild TF, Malvoisin E, Buckland R (1991) Measles virus: both the haemagglutinin and fusion glycoproteins are required for fusion. J Gen Virol 72:439–442
Wild TF, Fayolle J, Beauverger P, Buckland R (1994) Measles virus fusion: role of the cysteine-rich region of the fusion glycoprotein. J Virol 68:7546–7548
Wilton AN, Johnstone RW, McKenzie IF, Purcell DF (1992) Strong associations between RFLP and protein polymorphisms for CD46. Immunogenetics 36:79–85
Xu C, Mao D, Holers VM, Palanca B, Cheng AM, Molina H (2000) A critical role for the murine complement regulator Crry in fetomaternal tolerance. Science 287:498–501 Yanagi Y, Takeda M, Ohno S (2006) Measles virus: cellular receptors, tropism and pathogenesis.J Gen Virol 87:2767–2779
Yanagi Y, Takeda M, Ohno S (2006) Measles virus: cellular receptors, tropism and pathogenesis.J Gen Virol 87:2767–2779
Yannoutsos N, Ijzermans JN, Harkes C et al (1996) A membrane cofactor protein transgenic mouse model for the study of discordant xenograft rejection. Genes Cell 1:409–419
Yu GH, Holers VM, Seya T, Ballard L, Atkinson JP (1986) Identification of a third component of complement-binding glycoprotein of human platelets. J Clin Invest 78:494–501
Zaffran Y, Destaing O, Roux A et al (2001) CD46/CD3 costimulation induces morphological changes of human T cells and activation of Vav, Rac, and extracellular signal-regulated kinase mitogen-activated protein kinase. J Immunol 167:6780–6785
Zheng XL, Sadler JE (2008) Pathogenesis of thrombotic microangiopathies. Annu Rev Pathol 3:249–277
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kemper, C., Atkinson, J.P. (2009). Measles Virus and CD46. In: Griffin, D.E., Oldstone, M.B.A. (eds) Measles. Current Topics in Microbiology and Immunology, vol 329. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-70523-9_3
Download citation
DOI: https://doi.org/10.1007/978-3-540-70523-9_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-70522-2
Online ISBN: 978-3-540-70523-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)